Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FY8XC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,789
Award facts
- Contract value 100% obligated
- $21,789.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,789.24 to Amerisourcebergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication used to treat chronic obstructive pulmonary disease. The contract was awarded on January 22, 2026, with an ultimate completion date of January 23, 2026, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be conducted at the awardee's corporate office location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is executed under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. This delivery order represents a routine pharmaceutical supply fulfillment within the framework of that strategic contracting vehicle established to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FY8XC?
SPE2DR26FY8XC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FY8XC worth?
The government has obligated $21,789 on SPE2DR26FY8XC.
Is contract SPE2DR26FY8XC an order under another contract?
Yes. SPE2DR26FY8XC is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8XC competed?
The extent of competition for SPE2DR26FY8XC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award